Skip to main content
All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for BAMBOO HEALTH · Healthcare and prescription drug monitoring

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Kentucky · House · Senate · $70,000.00 income · posted Apr 20, 2026

Official filing document

 Lobbying activity 2
Health Issues

Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75); Issues related to the SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to Medicare Program policy for Contract Year 2027 and technical changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program Proposed Rule; Issues related to Fiscal Year 2027 appropriations report language concerning Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS), and Commerce, Justice, Science, and Related Agencies (CJS).

Medicare/Medicaid

Issues related to behavioral health services and care coordination (including Medicare and Medicaid); Issues related to Medicare Program policy for Contract Year 2027 and technical changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program Proposed Rule; Issues related to Fiscal Year 2027 appropriations report language concerning Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem